Kif2a and HER2 expression in breast cancer tissue chip and their prognostic significance

被引：0
|
作者：
Zhu, Yan [1 ]
Liu, Hong-Bin [1 ]
Yang, Qi-Chang [1 ]
Zhang, Xiao-Juan [1 ]
Shen, Yi [1 ]
Sun, Yong-Qiang [2 ]
机构：
[1] First Peoples Hosp Nantong, Dept Pathol, Nantong, Jiangsu, Peoples R China
[2] First Peoples Hosp Nantong, Dept Surg, Nantong, Jiangsu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 08期
关键词：
Kif2a; HER2; tissue chip; breast cancer; immunohistochemistry; prognosis; CENTROMERE-ASSOCIATED KINESIN; OVEREXPRESSION; PROTEIN; CELLS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Objective: To investigate and evaluate the expression of Kif2a and HER2 in breast cancer tissue chip and their prognostic significance. Methods: The Kif2a and HER2 expression were detected in the cancer and adjacent tissues of 102 patients with breast cancer by tissue chip and immunohistochemistry. The 62 patients were recieved follow-up, and results were analyzed by single factor analysis or Cox regression analysis. Results: There was positive correlation between the expression of Kif2a and HER 2 in breast cancer with different TNM grade and lymph node metastasis (P < 0.05). Kif2a was positively correlated to HER2 (P < 0.01). In the following up of the 62 patients, the results of single factor analysis showed that the survival rate was correlated to the expression of Kif2a and HER2, TNM grade and lymph node metastasis, which was with independently prognostic significance by Cox regression analysis. Conclusion: Kif2a and HER2 expressions in breast cancer tissue were positively correlated to TNM grade and lymph node metastasis (P < 0.05). The expressions of Kif2a and HER2 were with important significance in the detection of potential metastasis of breast cancer and the evaluation of prognosis.
引用
收藏
页码：15394 / 15399
页数：6
相关论文
共 50 条
  • [31] Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer
    Xiong, Zhongtang
    Liu, Kai
    Liu, Shaoyan
    Feng, Jiahao
    Wang, Jin
    Feng, Zewen
    Lai, Boan
    Zhang, Qingxin
    Jiang, Qingping
    Zhang, Wei
    BMC CANCER, 2024, 24 (01)
  • [32] Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer
    Zhu, Xiaoli
    Lu, Yongming
    Lu, Hongfen
    Yang, Wentao
    Tu, Xiaoyu
    Cai, Xu
    Zhou, Xiaoyan
    HUMAN PATHOLOGY, 2011, 42 (10) : 1499 - 1504
  • [33] Serum HER2 as potential prognostic biomarker in primary breast cancer patients
    Todorovic-Rakovic, Natasa
    Milovanovic, Jelena
    Radulovic, Marko
    Greenman, John
    GROWTH FACTORS, 2025, : 37 - 44
  • [34] Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics
    Liu, Xiangdong
    Zheng, Yan
    Qiao, Chuanwu
    Qv, Fei
    Wang, Jingnan
    Ding, Butong
    Sun, Yuping
    Wang, Yunshan
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [35] Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer
    Rossi, Valentina
    Sarotto, Ivana
    Maggiorotto, Furio
    Berchialla, Paola
    Kubatzki, Franziska
    Tomasi, Nicoletta
    Redana, Stefania
    Martinello, Rossella
    Valabrega, Giorgio
    Aglietta, Massimo
    Ponzone, Riccardo
    Montemurro, Filippo
    ONCOLOGIST, 2012, 17 (11) : 1418 - 1425
  • [36] Serum HER2 supports HER2-testing in tissue at the time of primary diagnosis of breast cancer
    Di Gioia, Dorit
    Dresse, Marie
    Mayr, Doris
    Nagel, Dorothea
    Heinemann, Volker
    Kahlert, Steffen
    Stieber, Petra
    CLINICA CHIMICA ACTA, 2014, 430 : 86 - 91
  • [37] KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer
    Wang, Jianli
    Ma, Siqin
    Ma, Rong
    Qu, Xun
    Liu, Wenjun
    Lv, Cuixia
    Zhao, Song
    Gong, Yunyun
    BMC CANCER, 2014, 14
  • [38] Breast Cancer and HER2 Over Expression
    Devgan, Manish
    Mohan, Ankur
    Gangwar, Pallavi
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2014, 3 (05): : 395 - 398
  • [39] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [40] Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks
    Ge, Xiaowen
    Wang, Haixing
    Zeng, Haiying
    Jin, Xuejuan
    Sujie, Akesu
    Xu, Chen
    Liu, Yalan
    Huang, Jie
    Ji, Yuan
    Tan, Yunshan
    Liu, Tianshu
    Hou, Yingyong
    Qin, Jing
    Sun, Yihong
    Qin, Xinyu
    HUMAN PATHOLOGY, 2015, 46 (06) : 850 - 857
12345